Search results
Results from the WOW.Com Content Network
John McCafferty is a British scientist, one of the founders of Cambridge Antibody Technology alongside Sir Gregory Winter and David Chiswell. He is well known as one of the inventors of scFv antibody fragment phage display, [1] a technology that revolutionised the monoclonal antibody drug discovery.
Phage display is also a widely used method for in vitro protein evolution (also called protein engineering). As such, phage display is a useful tool in drug discovery. It is used for finding new ligands (enzyme inhibitors, receptor agonists and antagonists) to target proteins.
PubMed is a free database including primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintains the database as part of the Entrez system of information retrieval .
A database primarily of references and abstracts on life sciences and biomedical topics. Includes MEDLINE, PubMed Central, and Bookshelf. Free NIH, NLM: RSWBplus [48] Civil Engineering, Architecture: 1,600,000 Bibliographic database for planning and building related publications, chronological coverage since 1975.
The journal Nucleic Acids Research regularly publishes special issues on biological databases and has a list of such databases. The 2018 issue has a list of about 180 such databases and updates to previously described databases. [2] Omics Discovery Index can be used to browse and search several biological databases.
CAT pioneered the application of Phage Display and Ribosome Display technology for the design and development of human monoclonal antibody therapeutics and which was reflected in the breadth of the company's patent portfolio. The Cambridge patent portfolio includes about 40 families of patents, covering both technologies and products.
Virulent Phage (Selected Papers in Biochemistry, Volume 1). University of Tokyo Press, Tokyo, and University Park Press, Baltimore, MD. OCLC 208390, ISBN 0-8391-0612-2; Tomizawa, J.-I., ed. 1971. Bacterial Genetics and Temperate Phage (Selected Papers in Biochemistry, Volume 2). University Park Press, Baltimore, MD. OCLC 200390, ISBN 0-8391-0611-4
Phage therapy has gained recent attention in the United States as an alternative to standard antibiotic therapy. [ 5 ] [ 6 ] [ 7 ] It has been in practice for just over 100 years in countries such as Russia and Georgia , but due to the recent clinical attention of antibiotic resistance , Western countries have slowly been integrating phage ...